TYRA NASDAQ
Tyra Biosciences, Inc.
1W: -9.6%
1M: -11.6%
3M: +4.6%
YTD: +23.2%
1Y: +230.9%
3Y: +159.0%
$32.47
-0.55 (-1.67%)
Weekly Expected Move ±7.2%
$32
$34
$37
$40
$42
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (20)
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of “Moderate Buy” by Analysts
Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at Buy on Strength of Lead Drug Dabogratinib
Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Tyra Biosciences (NASDAQ:TYRA) Director Sells $528,486.15 in Stock
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
Boothbay Fund Management LLC Makes New $2.61 Million Investment in Tyra Biosciences, Inc. $TYRA
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of “Moderate Buy” by Brokerages
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year High – What’s Next?
HC Wainwright Issues Optimistic Forecast for TYRA Earnings
Tyra Biosciences GAAP EPS of -$0.57 misses by $0.04
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium
AquaBounty Technologies (NASDAQ:AQB) versus Tyra Biosciences (NASDAQ:TYRA) Head to Head Analysis
Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of “Moderate Buy” from Brokerages
Tyra Biosciences (NASDAQ:TYRA) Hits New 1-Year High – Here’s Why
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer